๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Management of adult acute leukemia a southwest oncology group study

โœ Scribed by Kenneth B. McCredie; Edmund A. Gehan; Emil J. Freireich; James S. Hewlett; Charles A. Coltman Jr.; Khader K. Hussein; Stanley P. Balcerzak; T. Timothy Chen


Publisher
John Wiley and Sons
Year
1983
Tongue
English
Weight
711 KB
Volume
52
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Adult acute leukemia studies utilizing c
โœ Coltman, Charles A. ;Freireich, Emil J. ;Pendleton, Olga ;Bickers, John N. ;Bode ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 467 KB

Four Southwest Oncology Group clinical trials in adult acute leukemia were conducted between June 1967 and January 1975 involving 741 adult patients. The trials involved Cytarabine (ARA-C) alone and in combination. The last patient started treatment Over five years ago and 81 of 741 (1 1%) survived

Adriamycin in combination chemotherapy o
โœ Shaw, Michael T. ;Raab, Spencer O. ๐Ÿ“‚ Article ๐Ÿ“… 1977 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 350 KB

## Abstract Eighteen (72%) of 25 evaluable and previously untreated patients with adult acute lymphoblastic leukemia entered complete remission (CR) following induction therapy with Adriamycin, vincristine, and prednisone in a Southwest Oncology Group study. Remission maintenance therapy with metho

Early deaths in newly diagnosed cases of
โœ Stephen L. George; Donald J. Fernbach; Elisa T. Lee ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 444 KB ๐Ÿ‘ 3 views

A reanalysis of all ten clinical trials conducted by the Southwest Oncology Group from 1958 through 1976 in newly diagnosed pediatric acute leukemia was carried out to quantify the "early death" rate (i.e., rate of deaths during the first four weeks of remission induction) and to determine factors r

Remission induction in acute myelogenous
โœ Steuber, C. Philip ;Humphrey, G. Bennett ;McMillan, Campbell W. ;Vietti, Teresa ๐Ÿ“‚ Article ๐Ÿ“… 1978 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 353 KB

The use of cytosine arabinoside (Ara-C) infused at kinetically suggested intervals is reported in 40 pediatric patients with acute myelogenous leukemia (AML) and its subtypes. Response was observed in 17 of the 34 evaluable patients. However, the severe, often fatal effects of the regimen prevent it